Clinical Trials Directory

Trials / Unknown

UnknownNCT06206590

Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates

Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates Born to ≤32-week Preterm Infants or Infected Mothers During Pregnancy

Status
Unknown
Phase
Study type
Observational
Enrollment
116 (estimated)
Sponsor
Guangdong Women and Children Hospital · Academic / Other
Sex
All
Age
1 Day – 1 Day
Healthy volunteers
Not accepted

Summary

1\. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic shock maternal influence factors. 2. Through maternal blood samples before delivery and labor cord blood sample screening and septic shock related proteomics analysis, explore the relationship between the difference protein and septic shock and prognosis, and explore the pathway mechanism, in order to prevent and reduce the occurrence of septic shock in premature infants

Detailed description

The birth cohort was established with 32 weeks of premature infants or maternal infection during pregnancy.Whole proteomic analysis was performed on maternal blood before delivery and umbilical cord blood samples at delivery,and screscreen differential proteins associated with septic shock and classify these proteins as leak factor into exposed and non-exposed groups for cohort study.The incidence and mortality of shock,severe brain injury and BPD in the two groups were compared, and the mechanism of the differential protein was studied to provide early warning in children with septic shock.

Conditions

Interventions

TypeNameDescription
OTHERWhole-proteomic assayWhole-proteomic analysis was performed on all the blood samples

Timeline

Start date
2023-11-01
Primary completion
2025-09-01
Completion
2025-12-31
First posted
2024-01-16
Last updated
2024-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06206590. Inclusion in this directory is not an endorsement.